Akazawa, H., Oda, K., Mitani, S., et al. (1998). Surgical management of hip dislocation in children with arthrogryposis multiplex congenita. Journal of Bone and Joint Surgery: British Volume, 80, 636-640.

American Academy of Pediatrics, Committee on Genetics. (1995). Health supervision for children with achondroplasia. Pediatrics, 95, 443-451.

Anlar, B. (2000). Juvenile myasthenia: Diagnosis and treatment. Paediatric Drugs, 2, 161-169.

Asbury, A.K. (2000). New concepts of Guillain-Barré syndrome. Journal of Child Neurology, 15, 183-191.

Bach, J.R., Niranjan, V., & Weaver, B. (2000). Spinal muscular atrophy type 1: A noninvasive respiratory management approach. Chest, 117, 1100-1105.

Bach, J.R., Rajaraman, R., Ballanger, F., et al. (1998). Neuromuscular ventilatory insufficiency: Effect of home mechanical ventilator use versus oxygen therapy on pneumonia and hospitalization rates. American Journal of Physical Medicine and Rehabilitation, 77, 8-19.

Barois, A., & Estournet-Mathiaud, B. (1997). Respiratory problems in spinal muscular atrophies. Pediatric Pulmonology, 16(Suppl.), 140-141.

Birch, J.G. (1998). Orthopedic management of neuromuscular disorders in children. Seminars in Pediatric Neurology, 5, 78-91.

Blakeslee T.J. (1997). Congenital idiopathic talipes equinovarus (clubfoot). Current concepts. Clinics in Podiatric Medicine and Surgery, 14, 9-56.

Bleck, E.E. (1993). Clubfoot. Developmental Medicine and Child Neurology, 35, 927-931.

Brueton, L.A., Huson, S.M., Cox, P.M., et al. (2000). Asymptomatic maternal myasthenia as a cause of the Pena-Shokeir phenotype. American Journal of Medical Genetics, 92, 1-6.

Burrows, N.P. (1999). The molecular genetics of the Ehlers-Danlos syndrome. Clinical and Experimental Dermatology, 24, 99-106.

Carolino, J., Perez, J.A., & Popa, A. (1998). Osteopetrosis. American Family Physician, 57, 1293-1296.

Coleman, S.S. (1993). Complex foot deformities in children. Philadelphia: Lea & Febiger.

Coleman, S.S. (1994). Developmental dislocation of the hip: Evolutionary changes in diagnosis and treatment. Journal of Pediatric Orthopedics, 14, 1-2.

Crawford, A.H., Mehlman, C.T., & Slovek, R.W. (1999). The fate of untreated developmental dislocation of the hip: Long-term follow-up of eleven patients. Journal of Pediatric Orthopedics, 19, 641-644.

Dormans, J.P. (1993). Orthopaedic management of children with cerebral palsy. Pediatric Clinics of North America, 40, 645-657.

Dubowitz, V. (1995). Muscle disorders in childhood (2nd ed.). Philadelphia: W.B. Saunders.

Dubowitz, V. (2000). Congenital muscular dystrophy: An expanding clinical syndrome. Annals of Neurology, 47, 143- 144.

Engel, A.G. (1999). Congenital myasthenic syndromes. Journal of Child Neurology, 14, 38-41.

Engel, A.G., Hutchinson, D.O., Nakano, S., et al. (1993). Myasthenic syndromes attributed to mutations affecting the epsilon subunit of the acetylcholine receptor. Annals of the New York Academy of Sciences, 681, 496-508.

Engelbert, R.H., Pruijs, H.E., Beemer, F.A., et al. (1998). Osteogenesis imperfecta in childhood: Treatment strategies. Archives in Physical Medicine and Rehabilitation, 79, 1590-1594.

Fasth, A., & Porras, O. (1999). Human malignant osteopetrosis: Pathophysiology, management and the role of bone marrow transplantation. Pediatric Transplantation, 3(Suppl. 1), 102-107.

Forlino, A., & Marini, J.C. (2000). Osteogenesis imperfecta: Prospects for molecular therapeutics. Molecular Genetics and Metabolism, 71(1-2), 225-232.

Gabos, P.G., Miller, F., Galban, M.A., et al. (1999). Prosthetic interposition arthroplasty for the palliative treatment of end-stage spastic hip disease in nonambulatory patients with cerebral palsy. Journal of Pediatric Orthopedics, 19, 796-804.

Gendron, N.H., & MacKenzie, A.E. (1999). Spinal muscular atrophy: Molecular pathophysiology. Current Opinion in Neurology, 12, 137-142.

Genkins, G., Sivak, M., & Tartter, P.I. (1993). Treatment strategies in myasthenia gravis. Annals of the New York Academy of Sciences, 681, 603-608.

Gerritsen, E.J., Vossen, J.M., van Loo, I.H., et al. (1994). Autosomal recessive osteopetrosis: Variability of findings at diagnosis and during the natural course. Pediatrics, 93, 247-253.

Glorieux, F.H., Bishop, N.J., Plotkin, H., et al. (1998). Cyclic administration of Pamidronate in children with severe osteogenesis imperfecta. New England Journal of Medicine, 14, 947-952.

Gordon, N. (1998). Arthrogryposis multiplex congenita. Brain Development, 20, 507-511.

Hadden, R.D., & Hughes, R.A. (1999). Treatment of immune-mediated inflammatory neuropathies. Current Opinion in Neurology, 12, 573-579.

Hall, J.G. (1997). Arthrogryposis multiplex congenita: Etiology, genetics, classification, diagnostic approach, and general aspects. Journal of Pediatric Orthopaedics: Part B, 6, 159-166.

Harvard, C.W., & Fonseca, A. (1990). New treatment approaches to myasthenia gravis. Drugs, 39, 66-73.

Ho, T., & Griffin, J. (1999). Guillain-Barré syndrome. Current Opinion in Neurology, 12, 389-394.

Hofmann, Y., Lorson, C.L., Stamm, S., et al. (2000). Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2). Proceedings of the National Academy of Sciences of the United States of America, 97, 9618-9623.

Horwitz, E.M., Prockop, D.J., Fitzpatrick, L.A., et al. (1999). Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nature Medicine, 5, 309-313.

Hughes, R.A., Hadden, R.D., Gregson, N.A., et al. (1999). Pathogenesis of Guillain-Barré syndrome. Journal of Neuroimmunology, 100(1-2), 74-97.

Hunter, A.G., Bankier, A., Rogers, J.G., et al. (1998). Medical complications of achondroplasia: A multicenter patient review. Journal of Medical Genetics, 35, 705-712.

Iannaccone, S.T. (1998). Spinal muscular atrophy. Seminars in Neurology, 18, 19-26.

Ikeda, K. (1992). Conservative treatment of idiopathic clubfoot. Journal of Pediatric Orthopedics, 12, 217-223.

Jablonka, S., Rossoll, W., Schrank, B., et al. (2000). The role of SMN in spinal muscular atrophy. Journal of Neurology, 247(Suppl. 1.), 137-142.

Jones, H.R., Jr. (2000). Guillain-Barré syndrome: Perspectives with infants and children. Seminars in Pediatric Neurology, 7, 91-102.

Kakulas, B.A. (1999). Problems and solutions in the rehabilitation of patients with progressive muscular dystrophy. Scandinavian Journal of Rehabilitation Medicine, 39(Suppl.), 23-37.

Kocher, M.S., & Shapiro, F. (1998). Osteogenesis imperfecta. The Journal of the American Academy of Orthopaedic Surgeons, 6, 225-236.

Kogut, K.A., Bufo, A.J., Rothenberg, S.S., et al. (2000). Thoracoscopic thymectomy for myasthenia gravis in children. Journal of Pediatric Surgery, 35, 1576-1577.

Lefebvre, S., Burglen, L., Frezal, J., et al. (1998). The role of the SMN gene in proximal spinal muscular atrophy. Human Molecular Genetics, 7, 1531-1536.

Lisak, R.P. (1999). Myasthenia gravis. Current Treatment Options in Neurology, 1, 239-250.

Matsui, Y., Yasui, N., Kimura, T., et al. (1998). Genotype phenotype correlation in achondroplasia and hypochondroplasia. The Journal of Bone and Joint Surgery: British Volume, 80, 1052-1056.

Mehler, M.F. (2000). Brain dystrophin, neurogenetics and mental retardation. Brain Research Reviews, 32, 277-307.

Menkes, J.H. (1995). Textbook of child neurology (5th ed.). Philadelphia: Lippincott Williams & Wilkins.

Miller, R.G. (1999). Carrell-Krusen Symposium invited lecture. Clinical trials in motor neuron diseases. Journal of Child Neurology, 14, 173-179.

Minch, C.M., & Kruse, R.W. (1998). Osteogenesis imperfecta: A review of basic science and diagnosis. Orthopedics, 21, 558-567, 568-569.

Morrissy, R.T. (1990). Lovell and Winter’s pediatric orthopedics (4th ed.). Philadelphia: Lippincott Williams & Wilkins.

Pascuzzi, R.M., & Fleck, J.D. (1997). Acute peripheral neuropathy in adults: Guillain-Barré syndrome and related disorders. Neurologic Clinics, 15, 529-547.

Paterson, C.R. (1997). Osteogenesis imperfecta and other heritable disorders of bone. Bailliere’s Best Practice and Research: Clinical Endocrinology and Metabolism, 11, 195-213.

Paterson, C.R., Ogston, S.A., & Henry, R.M. (1996). Life expectancy in osteogenesis imperfecta. British Medical Journal, 312, 351.

Phillips, D.P., Roye, D.P., Farcy J.P., et al. (1990). Surgical treatment of scoliosis in a spinal muscular atrophy population. Spine, 15, 942-945.

Polizzi, A., Huson, S.M., & Vincent, A. (2000). Teratogen update: Maternal myasthenia gravis as a cause of congenital arthrogryposis. Teratology, 62, 332-341.

Qu, Z., & Huard J. (2000). Matching host muscle and donor myoblasts for myosin heavy chains improves myoblast transfer therapy. Gene Therapy, 7, 428-437.

Quan, A., Adams, R., Ekmark, E., et al. (1998). Bone mineral density in children with myelomeningocele. Pediatrics, 102, E34.

Qureshi, A.I., & Suri, M.F. (2000). Plasma exchange for treatment of myasthenia gravis: Pathophysiologic basis and clinical experience. Therapeutic Apheresis, 4, 280- 286.

Raff, M.L., & Byers, P.H. (1996). Joint hypermobility syndromes. Current Opinion in Rheumatology, 8, 459-466.

Ramaswami, U., Rumsby, G., Spoudeas, H.A., et al. (1999). Treatment of achondroplasia with growth hormone: Six years of experience. Pediatric Research, 46, 435-439.

Reitter, B. (1995). Deflazacort vs. prednisone in Duchenne muscular dystrophy: Trends of an ongoing study. Brain and Development, 17(Suppl.), 36-43.

Robertson, G.S., Crocker, S.J., Nicholson, D.W., et al. (2000). Neuroprotection by the inhibition of apoptosis. Brain Pathology, 10, 283-292.

Roebuck, D.J. (1999). Skeletal complications in pediatric oncology patients. Radiographics, 19, 873-885.

Roland, E.H. (2000). Muscular dystrophy. Pediatrics in Review, 21, 233-237, 238.

Salter, R.B., & Harris, W.R. (1963). Injuries involving the epiphyseal plate. Journal of Bone and Joint Surgery, American Volume, 45, 587-622.

Sambrook, P.N., & Jones, G. (1995). Corticosteroid osteoporosis. British Journal of Rheumatology, 34, 8-12.

Shaw, N.J., White, C.P., Fraser, W.D., et al. (1994). Osteopenia in cerebral palsy. Archives of Disease in Childhood, 71, 235-238.

Shohat, M., Lotan, R., Magal, N., et al. (1997). A gene for arthrogryposis multiplex congenita neuropathic type is linked to D5S394 on chromosome 5qter. American Journal of Human Genetics, 61, 1139-1143.

Skuk, D., Goulet, M., Roy, B., et al. (2000). Myoblast transplantation in whole muscle of nonhuman primates. Journal of Neuropathology and Experimental Neurology, 59, 197- 206.

Sodergard, J., Hakamies-Blomqvist, L., Sainio, K., et al. (1997). Arthrogryposis multiplex congenita: Perinatal and electromyographic findings, disability, and psychosocial outcome. Journal of Pediatric Orthopedics: Part B, 6, 167- 171.

Song, K.M., & Lapinsky, A. (2000). Determination of hip position in the Pavlik harness. Journal of Pediatric Orthopedics, 20, 317-319.

Stewart, H., Wallace, A., McGaughran, J., et al. (1998). Molecular diagnosis of spinal muscular atrophy. Archives of Disease in Children, 78, 531-535.

Strober, J.B., & Tennekoon, G.I. (1999). Progressive spinal muscular atrophies. Journal of Child Neurology, 14, 691- 695.

Swoboda, K.J., Specht, L., Jones, H.R., et al. (1997). Infantile phosphofructokinase deficiency with arthrogryposis: Clinical benefit of a ketogenic diet. Journal of Pediatrics, 131, 932-934.

Talbot, K. (1999). Spinal muscular atrophy. Journal of Inherited Metabolic Disease, 22, 545-554.

Tanaka, H. (1997). Achondroplasia: Recent advances in diagnosis and treatment. Acta Paediatrica Japonica, 39, 514-520.

Tawil, R. (1999). Outlook for therapy in the muscular dystrophies. Seminars in Neurology, 19, 81-86.

Tsao, C.Y., & Mendell, J.R. (1999). The childhood muscular dystrophies: Making order out of chaos. Seminars in Neurology, 19, 9-23.

Tzeng, A.C., Cheng, J., Fryczynski, H., et al. (2000). A study of thyrotropin-releasing hormone for the treatment of spinal muscular atrophy: A preliminary report. American Journal of Physical Medicine and Rehabilitation, 79, 435-440.

Urtizberea, J.A. (2000). Therapies in muscular dystrophy: Current concepts and future prospects. European Neurology, 43, 127-132.

Vardon, D., Chau, C., Sigodi, S., et al. (1998). Congenital rapidly fatal form of nemaline myopathy with fetal hydrops and arthrogryposis case report and review. Fetal Diagnosis and Therapy, 13, 244-249.

Vedeler, C.A. (2000). Inflammatory neuropathies: Update. Current Opinion in Neurology, 13, 305-309.

Vielhaber, S., Feistner, H., Schneider, W., et al. (2000). Mitochondrial complex I deficiency in a female with multiplex arthrogryposis congenita. Pediatric Neurology, 22, 53-56.

Wall, J.E., Kaste, S.C., Greenwald, C.A., et al. (1996). Fractures in children treated with radiotherapy for soft tissue sarcoma. Orthopedics, 19, 657-664.

Wallace, D.C. (2000). Mitochondrial defects in cardiomyopathy and neuromuscular disease. American Heart Journal, 139(2, Pt. 3), S70-S85.

Widemann, R.F., Bitan, F.D., Laplaza, F.J., et al. (1999). Spinal deformity, pulmonary compromise, and quality of life in osteogenesis imperfecta. Spine, 24, 1673.

Wirth, B. (2000). An update of the mutation spectrum of the survival motor neuron gene (SMN1)n autosomal recessive spinal muscular atrophy (SMA). Human Mutation, 15, 228–237.

Yingsakmongkol, W., & Kumar, S.J. (2000). Scoliosis in arthrogryposis multiplex congenita: Results after nonsurgical and surgical treatment. Journal of Pediatric Orthopedics, 20, 656–661.

Zori, R.T., Gardner, J.L., Zhang, J., et al. (1998). Newly described form of X-linked arthrogryposis maps to the long arm of the human X chromosome. American Journal of Medical Genetics, 78, 450–454.